Dechra Pharmaceuticals has been granted a patent for non-aqueous compositions containing macrolide antibiotics, specifically azithromycin, with low toxicity for feline administration. The composition includes specific solvents and a surfactant, providing a novel formulation for veterinary use. GlobalData’s report on Dechra Pharmaceuticals gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Dechra Pharmaceuticals, was a key innovation area identified from patents. Dechra Pharmaceuticals's grant share as of May 2024 was 41%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US12005071B2) discloses a non-aqueous composition for treating infections, comprising a macrolide, at least two solvents, and a surfactant. The composition includes specific solvents such as triacetin and triglycerides, with the macrolide azithromycin being a key component. The surfactant options include Polyoxyl 15 Hydroxystearate, among others, with precise percentages of each ingredient outlined in the claims.
Furthermore, the patent also covers a method of treating infections in subjects weighing less than 100 pounds by administering the disclosed composition. The method allows for the combination of the composition with additional antibiotics for enhanced efficacy. Specific details regarding the administration of the composition, including the use of injection and the potential application in feline subjects, are also highlighted in the claims. Overall, the patent provides a detailed framework for formulating and utilizing the non-aqueous composition effectively in treating infections, particularly in smaller subjects, with a focus on precise ingredient proportions and administration methods.
To know more about GlobalData’s detailed insights on Dechra Pharmaceuticals, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
